6-Thio-Deoxyguanosine: A novel telomerase-mediated therapy for oligodendroglioma linking cell-intrinsic DNA damage to immune activation

Administered By

Awarded By

Contributors

Start/End

  • July 20, 2021 - July 19, 2023